Related Experiment Video
Updated: Dec 12, 2025

Rapid Detection of Neurodevelopmental Phenotypes in Human Neural Precursor Cells NPCs
Published on: March 2, 2018
The phenomenal epigenome in neurodevelopmental disorders.
Ummi Ciptasari1, Hans van Bokhoven1,2
1Department of Human Genetics, Donders Institute for Brain, Cognition and Behavior, Radboud university medical center, 6500 HB Nijmegen, The Netherlands.
Epimutations disrupt chromatin structure, causing neurodevelopmental disorders called chromatinopathies. Convergent molecular and cellular disruptions across diverse genetic causes suggest shared targets for therapeutic interventions.
Area of Science:
- Genetics
- Molecular Biology
- Neuroscience
Background:
- Epimutations disrupting chromatin structure are a primary genetic cause of neurodevelopmental disorders (chromatinopathies).
- Diverse genetic mutations converge on molecular networks, cellular processes, and higher-order cellular functions in these disorders.
Purpose of the Study:
- To investigate the convergence of molecular and cellular disruptions in chromatinopathies.
- To identify shared pathways and processes that could be targeted for therapeutic interventions.
Main Methods:
- Analysis of gene mutations associated with various chromatinopathies.
- Examination of molecular networks, protein interactions, and cellular pathways affected by these mutations.
- Correlation of molecular and cellular disruptions with observed phenotypic features.
Main Results:
- A convergence was observed from diverse mutated genes to common molecular networks, pathways, and cellular processes.
- Disrupted cellular and subcellular processes lead to impaired higher-order cellular network function.
- Specific shared phenotypic features across different chromatinopathies reflect underlying molecular and cellular convergence.
Conclusions:
- Common molecular and cellular anomalies in chromatinopathies offer potential targets for symptomatic interventions.
- This convergence provides a rational basis for developing treatments for distinct groups of neurodevelopmental disorders.
- Targeting shared disrupted pathways may lead to effective therapies for genetically diverse chromatinopathies.
More Related Videos
13:11Optimized Analysis of DNA Methylation and Gene Expression from Small, Anatomically-defined Areas of the Brain
Published on: July 12, 2012
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Nucleosome Remodeling
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...